Cargando…

Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma

BACKGROUND: To investigate the expression and clinical significance of EFNA1 in broad-spectrum tumors, and to evaluate its relationship with prognosis and biological functions of esophageal carcinoma (ESCA). METHODS: EFNA1 expression in various cancers was analyzed according to the data in the TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yongqiang, Zhang, Jinning, Pan, Guanlong, Guan, Tianhao, Zhang, Changhao, Hao, An, Li, Yan, Ren, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369630/ https://www.ncbi.nlm.nih.gov/pubmed/34399788 http://dx.doi.org/10.1186/s12957-021-02362-8

Ejemplares similares

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma
por: Deng, Mingming, et al.
Publicado: (2021)

Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
por: Jiang, Houxiang, et al.
Publicado: (2023)

EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance
por: Chu, Ling-Yu, et al.
Publicado: (2022)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma
por: Hao, Yong-Ping, et al.
Publicado: (2021)

Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer
por: Jiao, Zonglin, et al.
Publicado: (2022)

Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
por: Li, Hailong, et al.
Publicado: (2022)

Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2
por: Yuan, Weidong, et al.
Publicado: (2022)

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Visual Maps Development: Reconsidering the Role of Retinal Efnas and Basic Principle of Map Alignment
por: Savier, Elise, et al.
Publicado: (2018)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis
por: Tung, Moon Ley, et al.
Publicado: (2022)

Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
por: Zhang, Li, et al.
Publicado: (2023)

An association study between DLGAP1 rs11081062 and EFNA5 rs26728 polymorphisms with obsessive–compulsive disorder in a Chinese Han population
por: Li, Jiang, et al.
Publicado: (2015)

Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy
por: Liang, Zheng, et al.
Publicado: (2021)

EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop
por: Lin, Junhao, et al.
Publicado: (2021)

Role of EFNA1 SNP (rs12904) in Tumorigenesis and Metastasis of Colorectal Cancer: A Bioinformatic Analysis and HRM SNP Genotyping Verification
por: Salem, Elham, et al.
Publicado: (2022)

DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma
por: Ju, Gaoda, et al.
Publicado: (2021)

CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction
por: Li, Jian, et al.
Publicado: (2016)

The 1q21.3 region driver gene EFNA3 promotes disease progression via inhibition of lung adenocarcinoma cell apoptosis
por: Dong, Chenchen, et al.
Publicado: (2022)

LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326/EFNA3 axis
por: Jiang, Bing, et al.
Publicado: (2022)

FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L
por: Zhou, Suna, et al.
Publicado: (2021)

Enhanced expression of early mitotic inhibitor-1 predicts a poor prognosis in esophageal squamous cell carcinoma patients
por: GUAN, CHENGQI, et al.
Publicado: (2016)

A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma
por: Shang, Li, et al.
Publicado: (2014)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis
por: Zhang, Xiao-Fei, et al.
Publicado: (2016)

Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis
por: Ma, Hai-Feng, et al.
Publicado: (2018)

Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma
por: Chan-Jun, Zhen, et al.
Publicado: (2023)

The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients
por: Wen, Jing, et al.
Publicado: (2016)

RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis
por: Feng, Yan-Fen, et al.
Publicado: (2018)

Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2017)

High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis
por: Gao, Yongyin, et al.
Publicado: (2023)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis
por: Wang, Qiang, et al.
Publicado: (2019)

Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma
por: Pan, Chuqing, et al.
Publicado: (2021)

ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4
por: Sun, Gaozhong, et al.
Publicado: (2020)

The Survival and Prognosis Characteristics of Primary Esophageal Small-Cell Carcinoma
por: Li, Jie, et al.
Publicado: (2022)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma
por: Lu, Xiangyun, et al.
Publicado: (2023)

SIRT1 expression is associated with lymphangiogenesis, lymphovascular invasion and prognosis in pN0 esophageal squamous cell carcinoma
por: Chen, Guan-qing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bkkm6jvpl0n361esi1nbk2rqi5